早泄药物治疗的现状及新进展  

Current status and new progress of drug therapy for premature ejaculation

作　　者：尚仕浩 张磊 陆军 敦鑫龙 张学学 袁建林 SHANG Shihao;ZHANG Lei;LU Jun;DUN Xinlong;ZHANG Xuexue;YUAN Jianlin(The Cadet Team 6 of School of Basic Medicine,Air Force Medical University,Xi an 710032;Department of Urology,Xijing Hospital,Air Force Medical University,Xi an 710032;Department of Urology,Xi an Daxing Hospital,Yan an University,Xi an 710016,China)

机构地区：[1]空军军医大学基础医学院学员六大队,陕西西安710032 [2]空军军医大学西京医院泌尿外科,陕西西安710032 [3]延安大学附属西安大兴医院泌尿外科,陕西西安710016

出　　处：《现代泌尿外科杂志》2023年第5期445-449,458,共6页Journal of Modern Urology

基　　金：国家自然科学基金项目(No.61971425);西京医院学科助推计划项目(No.XJZT18D05)。

摘　　要：早泄(PE)是最常见的男性性功能障碍,发病率高,严重影响夫妻感情和家庭和谐。药物治疗是早泄患者的一线治疗方法,疗效较好,但是临床可用药品单一且弃用率高,加上部分患者治疗无效,新药研发迫在眉睫。本文通过系统综述目前早泄药物治疗的现状,重点关注新药的研发和研究进展,以期望为临床医生提供参考。Premature ejaculation(PE)is the most common male sexual dysfunction with a high incidence,which seriously affects the relationship between a husband and wife and family harmony.Drug therapy is a first-line treatment for PE patients with premature ejaculation,and has achieved good efficacy,but the clinically available drugs are single and the abandonment rate is high.Coupled with the ineffective treatment of some patients,new drug research and development is imminent.This paper systematically reviews the current status of drug treatment for premature ejaculation,focusing on the research and development of new drugs and research progress in order to provide a reference for clinicians.

关 键 词：早泄 药物治疗 新药研发 性功能障碍 

分 类 号：R698[医药卫生—泌尿科学]